Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy.
about
Evidence for pleiotropic factors in genetics of the musculoskeletal systemGenetics of the musculoskeletal system: a pleiotropic approachManaging sarcopenia and its related-fractures to improve quality of life in geriatric populations.Lean mass predicts asthma better than fat mass among females.Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studiesSimilarities in acquired factors related to postmenopausal osteoporosis and sarcopenia.Sarcopenia: An emphasis on occlusion training and dietary protein.Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study.Bone and skeletal muscle: neighbors with close tiesResistance exercise: good for more than just Grandma and Grandpa's muscles.Effect of estrogenic compounds (estrogen or phytoestrogens) combined with exercise on bone and muscle mass in older individuals.Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and women.Influence of hormone replacement therapy on eccentric exercise induced myogenic gene expression in postmenopausal women.Thigh muscle volume in relation to age, sex and femur volume.Sarcopenia and functional decline: pathophysiology, prevention and therapy.Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment.Female hormones: do they influence muscle and tendon protein metabolism?Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults.Interventions for Human Frailty: Physical Activity as a Model.The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.Development of a simple screening test for sarcopenia in older adults.Skeletal muscle and bone: effect of sex steroids and aging.Effects of ultra-low-dose estrogen therapy on muscle and physical function in older women.The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer.Endogenous hormones, muscle strength, and risk of fall-related fractures in older women.Effects of inspiratory muscle training in elderly women on respiratory muscle strength, diaphragm thickness and mobility.Methods, diagnostic criteria, cutoff points, and prevalence of sarcopenia among older people.Dietary Intake, Prevalence, and the Effect of Anemia on Various Morphophysiological Variables of Postmenopausal Women of North India.
P2860
Q28603505-933E2784-7FB4-4AFB-975F-5A729092ABCCQ28732063-A8314013-9639-430B-8071-3A0E603CDDF4Q33962042-23FE269F-21CB-4531-8439-925FEE96457BQ34299999-180B62C8-DF78-456B-9600-F936A7A3DD23Q34666496-33E0BFF5-E87A-462C-BF36-CDC3F031CA6BQ35195120-37B9F65E-DC12-44EF-AEA9-ACEA314E918CQ35532443-4DAA34C8-DBE5-42F4-837E-6D80C96B5A46Q36712178-5BFC4C71-81C5-4B26-B2D2-021520C48C84Q36968228-6AC4E069-E273-40B0-9D5D-63295F6332E8Q37024577-F8C7052C-0E60-4D64-8CC5-C3C606E0A746Q37112572-F88933CE-6713-4E13-B29C-53930E9C0022Q37188191-5726D199-D0A5-48A0-97E6-4B6CDF06A593Q37422184-80CA357D-E675-4DDB-9D58-26A39A4A0EA4Q37471014-2D1382C2-8C05-4D32-9B0D-1605373A7B49Q37610099-F7EC58A3-B661-4A27-8A4A-924AD367DCFBQ38345471-8F2FE30E-D367-46EA-A882-B2DA6D5BA5D7Q38605429-218B68BE-7748-4756-98F6-75E7B2D8AEB0Q38790597-FBB403F8-DA53-4DAB-82EF-5B3A0E939C5EQ38825015-2EC9B0D1-8264-4A72-84AF-F33B0D84CD55Q38842194-ABC8F1BF-A63D-4597-9D03-08D11FF0BBB2Q44298635-6346484D-EAA5-450A-B8E9-3D8D497BEC72Q46551247-CC954604-727F-4DB8-A196-AC91186FB7FEQ46793921-03F2BB42-4A49-4053-81AF-D90E446AF37EQ46877628-AAE38C74-6311-40CE-A062-AEC56E31FB66Q46925977-B4175305-76E0-476C-ABB6-94242FCD6A4FQ51684080-31A1B83F-996C-4C1C-95A9-F8EA1D16CEDAQ53646512-1B0F01C0-2D86-4226-A91C-35A4F8726E2AQ55386426-89169E71-66B2-4169-B18E-E70C278593F9
P2860
Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Prevalence of sarcopenia and p ...... estrogen-replacement therapy.
@en
Prevalence of sarcopenia and p ...... estrogen-replacement therapy.
@nl
type
label
Prevalence of sarcopenia and p ...... estrogen-replacement therapy.
@en
Prevalence of sarcopenia and p ...... estrogen-replacement therapy.
@nl
prefLabel
Prevalence of sarcopenia and p ...... estrogen-replacement therapy.
@en
Prevalence of sarcopenia and p ...... estrogen-replacement therapy.
@nl
P2093
P2860
P356
P1476
Prevalence of sarcopenia and p ...... estrogen-replacement therapy.
@en
P2093
Alison Kleppinger
Anne M Kenny
James O Judge
Latesha Dawson
Michele Iannuzzi-Sucich
P2860
P304
P356
10.1093/GERONA/58.5.M436
P407
P577
2003-05-01T00:00:00Z